Estimating the Proportion of Pneumonia Attributable to Pneumococcus in Kenyan Adults: Latent Class Analysis

Background: Community-acquired pneumonia is a common cause of hospitalization among African adults, and Streptococcus pneumoniae is assumed to be a frequent cause. Pneumococcal conjugate vaccine is currently being introduced into childhood immunization programs in Africa. The case for adult vaccination is dependent on the contribution of the pneumococcus to the hospital pneumonia burden. Methods: Pneumococcal diagnosis is complex because there is no gold standard, and culture methods are invalidated by antibiotic use. We used latent class analysis to estimate the proportion of pneumonia episodes caused by pneumococcus. Furthermore, we extended this methodology to evaluate the effect of antimicrobial treatment on test accuracies and the prevalence of the disease. The study combined data from 5 validation studies of pneumococcal diagnostic tests performed on 281 Kenyan adults with pneumonia. Results: The proportion of pneumonia episodes attributable to pneumococcus was 0.46 (95% confidence interval = 0.36–0.57). Failure to account for the effect of antimicrobial exposure underestimates this proportion as 0.32. A history of antibiotic exposure was a poor predictor of antimicrobial activity in patients' urine. Blood culture sensitivity for pneumococcus was estimated at 0.24 among patients with antibiotic exposure, and 0.75 among those without. Conclusions: The large contribution of pneumococcus to adult pneumonia provides a strong case for the investigation of pneumococcal vaccines in African adults.

[1]  G. Carlone,et al.  Confirmation of psaA in All 90 Serotypes ofStreptococcus pneumoniae by PCR and Potential of This Assay for Identification and Diagnosis , 2000, Journal of Clinical Microbiology.

[2]  J. Scott,et al.  Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya , 2000, The Lancet.

[3]  J. Hagenaars.  Latent Structure Models with Direct Effects between Indicators , 1988 .

[4]  R. Freeman,et al.  PCR Can Add to Detection of Pneumococcal Disease in Pneumonic Patients Receiving Antibiotics at Admission , 2000, Journal of Clinical Microbiology.

[5]  S. Allen.  Lobar pneumonia in Northern Zambia: clinical study of 502 adult patients. , 1984, Thorax.

[6]  S. Jaffar,et al.  Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants , 1997, The Lancet.

[7]  A. Hall,et al.  The value and complications of percutaneous transthoracic lung aspiration for the etiologic diagnosis of community-acquired pneumonia. , 1999, Chest.

[8]  D. Murdoch,et al.  Evaluation of a PCR Assay for Detection of Streptococcus pneumoniae in Respiratory and Nonrespiratory Samples from Adults with Community-Acquired Pneumonia , 2003, Journal of Clinical Microbiology.

[9]  R. Auckenthaler,et al.  Adult response to initial treatment with ampicillin in community acquired pneumonia in Yaoundé, Cameroon. , 1993, The Central African journal of medicine.

[10]  S. Jaffar,et al.  Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. , 1997, Lancet.

[11]  R. Mugerwa,et al.  Community-acquired pneumonia in Ugandan adults: short-term parenteral ampicillin therapy for bacterial pneumonia. , 2001, The American journal of tropical medicine and hygiene.

[12]  T. Marrie,et al.  Community-acquired pneumonia requiring hospitalization: 5-year prospective study. , 1989, Reviews of infectious diseases.

[13]  C. Black,et al.  Evaluation of polymerase chain reaction for diagnosis of pneumococcal pneumonia , 1993, Journal of clinical microbiology.

[14]  M. Leinonen,et al.  Evaluation of a new tube latex agglutination test for detection of type-specific pneumococcal antigens in urine , 1991, Journal of clinical microbiology.

[15]  P. Albert,et al.  A Cautionary Note on the Robustness of Latent Class Models for Estimating Diagnostic Error without a Gold Standard , 2004, Biometrics.

[16]  G. Waterer,et al.  A quantitative LightCycler PCR to detect Streptococcus pneumoniae in blood and CSF. , 2003, Diagnostic microbiology and infectious disease.

[17]  C. Fuchs.  Maximum Likelihood Estimation and Model Selection in Contingency Tables with Missing Data , 1982 .

[18]  S. Obaro,et al.  Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial , 2005, The Lancet.

[19]  M S Pepe,et al.  Using a combination of reference tests to assess the accuracy of a new diagnostic test. , 1999, Statistics in medicine.

[20]  Pneumonia and influenza death rates--United States, 1979-1994. , 1995, MMWR. Morbidity and mortality weekly report.

[21]  Russell V. Lenth,et al.  Statistical Analysis With Missing Data (2nd ed.) (Book) , 2004 .

[22]  J. Schafer,et al.  Missing data: our view of the state of the art. , 2002, Psychological methods.

[23]  M. Leinonen,et al.  Validation of Immune-Complex Enzyme Immunoassays for Diagnosis of Pneumococcal Pneumonia among Adults in Kenya , 2000, Clinical Diagnostic Laboratory Immunology.

[24]  吉嶺 裕之.  Community-acquired pneumonia in Ugandan adults : Short-term parenteral ampicillin therapy for bacterial pneumonia , 2002 .

[25]  J. Dorca,et al.  Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  M. Lorente,et al.  Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study , 2000, Thorax.

[27]  A. Schuchat,et al.  Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. , 2003, The Journal of infectious diseases.

[28]  L. Bélec,et al.  Acute community-acquired bacterial pneumonia in Human Immunodeficiency Virus (HIV) infected and non-HIV-infected adult patients in Cameroon: aetiology and outcome. , 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[29]  J. Schafer,et al.  A comparison of inclusive and restrictive strategies in modern missing data procedures. , 2001, Psychological methods.

[30]  R. Hayes,et al.  Admissions to a rural hospital in the West Nile District of Uganda over a 27 year period. , 1986, The Journal of tropical medicine and hygiene.

[31]  M. Leinonen,et al.  Comparison of a Pneumococcal Common Protein (PsaA) Antibody ELISA and a PsaA Immune Complex ELISA for Detection of Pneumococcal Serum Antibody , 1998, Pathobiology.

[32]  J. Macfarlane,et al.  Mycoplasma pneumoniae and the aetiology of lobar pneumonia in northern Nigeria. , 1979, Thorax.

[33]  D. Musher,et al.  Nonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  O. Sow,et al.  Community acquired pneumonia in adults: a study comparing clinical features and outcome in Africa (Republic of Guinea) and Europe (France). , 1996, Thorax.

[35]  Nicole A. Lazar,et al.  Statistical Analysis With Missing Data , 2003, Technometrics.

[36]  K. Marsh,et al.  Diagnosis of Pneumococcal Pneumonia by psaA PCR Analysis of Lung Aspirates from Adult Patients in Kenya , 2003, Journal of Clinical Microbiology.

[37]  T. Kohlmann,et al.  Latent class analysis in medical research , 1996, Statistical methods in medical research.

[38]  P S Albert,et al.  Latent Class Modeling Approaches for Assessing Diagnostic Error without a Gold Standard: With Applications to p53 Immunohistochemical Assays in Bladder Tumors , 2001, Biometrics.

[39]  B. Lowe,et al.  Serotype distribution and prevalence of resistance to benzylpenicillin in three representative populations of Streptococcus pneumoniae isolates from the coast of Kenya. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  J. Scott,et al.  The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. , 1999, Vaccine.

[41]  K. Marsh,et al.  Diagnosis of pneumococcal pneumonia in epidemiological studies: evaluation in Kenyan adults of a serotype-specific urine latex agglutination assay. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  K. Marsh,et al.  Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in Kenya. , 2002, The Journal of infectious diseases.